Effect of Use of DryNites Absorbent Pants on the Rate of Spontaneous Resolution of Paediatric Nocturnal Enuresis (NE)
About the study
Children vary in the age at which they achieve night-time dryness; in almost all cases children will stop bed-wetting without any need for treatment. Use of absorbent pants for the management of nocturnal enuresis is controversial regarding the impact on the speed at which children become dry throughout the night. The aim of this study is to determine the effect of using DryNites absorbent pants in children with monosymptomatic nocturnal enuresis on the speed they become dry throughout the night compared with removing absorbent pants.
Who can take part
You may be eligible to participate in the study if you meet the following criteria:
INCLUSION CRITERIA
Inclusion Criteria:
- Patient aged between 4-8 years at the time of enrollment
- Have a clinical diagnosis of monosymptomatic primary NE
- Have been dry in the day for >/= 6 months prior to enrollment
- Have on average no more than 1 dry night per month during the past 6 months at enrollment
- Have an informed consent signed by the their parent(s)/carer(s)
EXCLUSION CRITERIA
Exclusion Criteria:
- Children in foster/court care
- Have implemented any previous intervention to address NE (use of prescribed alarm schedule, desmopressin, imipramine, anticholinergics) or withdrawal of pants/nappies for > 7 days in the previous 6 months
- Have secondary NE
- Have wetting in the day
- Have faecal soiling
- Have known urinary tract disease
- Have diabetes
- Receive any regular intake of medication
- Have a known developmental/neurological disorder
- Have links to Kimberly-Clark of any kind (including family relations employed by Kimberly-Clark, holding stocks or share in Kimberly-Clark)
Study Locations
Enter your ZIP code/Postal code/PIN code to locate study sites near you:
How to Apply
Contact the study center to learn if this study is a good match for you.
Study’s details
Contition
Nocturnal Enuresis
Age (in years)
4 - 8
Phase
Not Applicable
Participants needed
120
Est. Completion Date
Dec 31, 2022
Treatment type
Interventional
Sponsor
Kimberly-Clark Corporation
ClinicalTrials.gov identifier
NCT04620356
Study number
KCC-DN-001
Understanding Clinical Trials
Get answers to your questions about clinical trials.What is a clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?